Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841710 · ClinicalTrials.gov registry record
Genetic Variability in Taste Perception
A clinical trial, sponsored by Monell Chemical Senses Center.
- Completed
- Registry status
- 90
- Enrollment target
NCT01841710: Completed study, sponsored by Monell Chemical Senses Center.
NCT01841710 is a clinical trial that has completed, run by Monell Chemical Senses Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01841710 has completed, sponsored by Monell Chemical Senses Center.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This proposal describes a pilot study aimed at determining whether genetic variations in taste receptors determine differential taste tolerability of pediatric medications.
Primary Outcome
Primary outcome variables are intensity ratings of pediatric medications as well as a variety of generally recognized as safe bitter and non-bitter compounds.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-12 |
What the finished NCT01841710 record still lists
NCT01841710 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01841710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01841710 about?
NCT01841710 is a clinical study titled "Genetic Variability in Taste Perception". This proposal describes a pilot study aimed at determining whether genetic variations in taste receptors determine differential taste tolerability of pediatric medications.
What is the current status of trial NCT01841710?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2012-12. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01841710?
This trial is sponsored by Monell Chemical Senses Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia